Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 22.85M P/E - EPS this Y - Ern Qtrly Grth -
Income -31.57M Forward P/E -0.61 EPS next Y - 50D Avg Chg -15.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -67.00%
Recommedations 2.00 Quick Ratio 0.52 Shares Outstanding 54.52M 52W Low Chg 26.00%
Insider Own 48.23% ROA -95.05% Shares Float 24.48M Beta 1.91
Inst Own 0.01% ROE - Shares Shorted/Prior 2.13M/0.96M Price 0.72
Gross Margin - Profit Margin - Avg. Volume 926,735 Target Price -
Oper. Margin - Earnings Date Oct 2 Volume 657,961 Change -0.01%
About Better Therapeutics, Inc.

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Better Therapeutics, Inc. News
03/14/24 Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
03/05/24 Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
03/04/24 Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
03/01/24 Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
02/20/24 Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
02/06/24 Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
01/18/24 David Perry Bought 8.6% More Shares In Better Therapeutics
01/17/24 Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
01/04/24 Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
01/03/24 Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings
01/02/24 Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
11/28/23 Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
BTTX Chatroom

User Image Zamasu_ Posted - 1 week ago

$ZONE - No shorts, no dilution, and a float that’s tighter than yoga pants. Feels like $BTTX before its pop. 📈

User Image Zamasu_ Posted - 1 week ago

$ZONE - Zero dilution, low float. Same kind of squeeze potential we saw with $BTTX earlier this year. 📈

User Image Zamasu_ Posted - 1 week ago

$ZONE - Zero dilution, low float. Same kind of squeeze potential we saw with $BTTX earlier this year. 📈

User Image Cenerentola Posted - 1 week ago

$BTTX How does BTTX stock still exist if Click Therapeutics bought its assets? Anybody know?

User Image DAKX Posted - 1 month ago

$BTTX Buy the dip🤣🤣!

User Image Cenerentola Posted - 3 months ago

@Virtuousxvillain @cheppy exactly - bunch of waanbe analysts all over stocktwits. no patience. they want a quick buck and 15 minutes of fame. same happened with $MYO - now look at it. I'm up like 325% for being patient. sometimes it sucks. like the ahole CEO of $BTTX doing us wrong in one overnight bullshit play. whatever shit happens.

User Image warren_puppett Posted - 3 months ago

$BTTX is the game over?

User Image joe13xx Posted - 3 months ago

$BTTX YES IT'S ALIVE!! BUT IT DEMANDS MORE 💸. IT WON'T PUMP WITHOUT PUMPERS!!

User Image SatoshisSpokeman Posted - 3 months ago

$BTTX is this alive?

User Image NVDAMillionaire Posted - 3 months ago

$BTTX Better Therapeutics, Inc. (BTTX): Pioneering Digital Therapeutics for Cardiometabolic Diseases http://beyondspx.com/2024/08/01/better-therapeutics-inc-bttx-pioneering-digital-therapeutics-for-cardiometabolic-diseases/

User Image john_iii Posted - 3 months ago

$BTTX Worse therapeutics

User Image N6608j Posted - 07/25/24

$BTTX : I think if I remember correctly, they hired somebody to be the CEO that was an expert on bankrupt companies. he probably sold this asset to pay off the first creditors…… remember the day before he was touting on the conference call that he was looking for investors and things were going well with the company? Then 2 or 3 days later they filed for bankruptcy !!

User Image RareBlueLobster Posted - 4 months ago

$BTTX This is such BS that a company can acquire the AspyreRx app without having to buy this out. Seems criminal. https://www.medicaldevice-network.com/news/click-therapeutics-acquires-assets-better-therapeutics/

User Image Bart69 Posted - 4 months ago

$BTTX getting a "no opening transactions are allowed on securities affected by amendments to sec rule 15c2-11" from Schwab.

User Image Brown12 Posted - 4 months ago

$BTTX what the fuck happen

User Image Bart69 Posted - 4 months ago

$BTTX WTF?

User Image SatoshisSpokeman Posted - 4 months ago

$BTTX ceo should be in shame for making me buying hes scam shit

User Image SatoshisSpokeman Posted - 4 months ago

$BTTX the app was good there no reaso to nput company in bankruptcy a modern company what a joke

User Image SatoshisSpokeman Posted - 4 months ago

$BTTX ceonis a joke wtf he doing

User Image N6608j Posted - 4 months ago

$BTTX : nice, but can you trade this stock ?

User Image Stocktrader365 Posted - 4 months ago

$BTTX I’m putting a few thousand into this tomorrow. Let’s pump this pig!

User Image snakecharm Posted - 4 months ago

$BTTX I kinda am!? I'm calling this my crypto stock ha ha! If it hits I'll have some good money, if not, I'll lose a little bit LFG hopefully

User Image N6608j Posted - 4 months ago

$BTTX : I’m kinda

User Image Stocktrader365 Posted - 4 months ago

$BTTX is there anyone on this board that’s active?

User Image Brown12 Posted - 06/28/24

$BTTX Any have any idea what’s going on ? Why so much movement

User Image Brown12 Posted - 06/27/24

$BTTX MASSSIVE end of day volume. 10X daily average and it’s not even moving

User Image Brown12 Posted - 06/27/24

$BTTX It and then lost 200% within a matter of hours. Just a massive scam.

User Image Stocktrader365 Posted - 06/27/24

$BTTX this is about to get pumped to .20 when we get below .01 again!! 🙃

User Image N6608j Posted - 06/27/24

$BTTX : With 2.2 million shares there must be something going on

User Image Brown12 Posted - 06/27/24

$BTTX gotta love obvious manipulation. Jumps 250% then crashes back down.

Analyst Ratings
Lake Street Buy Aug 10, 23
Chardan Capital Buy Aug 10, 23
Lake Street Buy Apr 14, 23
Chardan Capital Buy Mar 31, 23
Chardan Capital Buy Nov 15, 22
Chardan Capital Buy Jul 29, 22
Chardan Capital Buy Mar 16, 22
Chardan Capital Buy Nov 24, 21
Cowen & Co. Outperform Nov 10, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERRY DAVID P Executive Chairman Executive Chairman Jul 27 Buy 0.7299 1,233,045 900,000 13,030,393 07/31/23
Berman Mark A. Chief Medical Office.. Chief Medical Officer Jul 27 Buy 0.7299 54,802 40,000 388,191 07/31/23
Armanino Andrew J. Director Director Jul 27 Buy 0.7299 274,010 200,000 728,368 07/31/23
Granger Elder Director Director Jul 27 Buy 0.7299 34,251 25,000 35,851 07/31/23
KARBE FRANK Chief Executive Offi.. Chief Executive Officer Jul 27 Buy 0.7299 137,005 100,000 429,429 07/31/23
Parker Geoffrey M. Director Director Jul 27 Buy 0.7299 685,025 500,000 1,028,055 07/31/23
Granger Elder Director Director May 16 Buy 0.8672 600 520 1,600 05/18/23
PERRY DAVID P See Remarks See Remarks Apr 10 Buy 0.83 4,969,697 4,124,849 3,636,364 04/12/23
PERRY DAVID P See Remarks See Remarks Sep 15 Buy 2.03 50,000 101,500 101,536 09/19/22
KARBE FRANK See Remarks See Remarks Sep 15 Buy 2.0939 50,000 104,695 50,000 09/15/22
Armanino Andrew J. Director Director Jun 14 Buy 1.3897 15,000 20,846 15,000 06/16/22
Heinen Mark See Remarks See Remarks Jun 10 Buy 1.56 5,000 7,800 20,000 06/10/22
Zamirowski Justin Chief Commercial Off.. Chief Commercial Officer May 16 Option 0.50 35,236 17,618 35,236 05/18/22
Armanino Andrew J. Director Director Mar 29 Buy 2.1405 40,000 85,620 126,328 03/31/22
Parker Geoffrey M. Director Director Mar 29 Buy 2.1487 15,000 32,230 15,000 03/31/22